Good Manufacturing Practice (GMP) is built on a set of fundamental principles that prioritize patient safety, product quality, and data integrity. These principles are codified in regulatory frameworks that, while similar in intent, vary in specific requirements across jurisdictions.

What Is the GMP Regulatory Framework?

GMP regulations require manufacturers to control all manufacturing operations, define processes clearly, validate critical steps, and maintain complete documentation. The framework rests on ten core principles: clear written procedures, adherence to procedures, proper facilities and equipment, trained personnel, regular audits, controlled changes, documentation of deviations, validated processes, contamination prevention, and continuous improvement.

Regulatory Framework

The World Health Organization (WHO) published its first GMP text in 1968 and continues to update its guidelines, which serve as the basis for many national regulations. The EU GMP Guidelines are legally binding through EU Directives 2003/94/EC and 91/412/EEC, while the FDA enforces GMP through 21 CFR Parts 210/211 for drugs and 21 CFR Part 820 for devices. PIC/S provides harmonized GMP standards across 50+ participating authorities, and ICH Q7 specifically addresses GMP for active pharmaceutical ingredients (APIs).

Key Requirements

Each framework mandates a Quality Management System with an independent Quality Unit responsible for release decisions. All require validation of processes, calibration of equipment, stability testing, and a system for handling complaints and recalls. Data integrity must be assured across paper and electronic records, with the FDA emphasizing this under 21 CFR Part 11.

Practical Implementation

Companies operating globally must comply with multiple frameworks simultaneously, often adopting the most stringent requirements for all sites. A Site Master File documents how each facility meets GMP standards, and regulatory inspections verify compliance. Harmonization efforts through ICH and PIC/S continue to reduce duplication.

Common Pitfalls

Organizations frequently underestimate the effort required to maintain compliance across evolving regulations. Divergent interpretations of the same GMP principle between FDA and EU inspectors can create confusion, and gaps often emerge when transferring processes between sites under different regulatory jurisdictions.

Conclusion

Understanding the interplay between WHO, EU, FDA, PIC/S, and ICH frameworks is essential for any global manufacturer. A robust GMP program meets the highest applicable standard, ensuring both compliance and product quality regardless of the market.